Why does it makes you suspicious?
The big story on all the news programs in the UK this evening concerns the results of Donanemab in early #Alzheimer disease. I have not read the paper yet. However, by the simple fact that the paper is published in JAMA rather than the @NEJM or @TheLancet makes me suspicious. pic.twitter.com/mXVYptIRFh
— Michael Makris (@ProfMakris) July 17, 2023